{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T15:59:01Z","timestamp":1791129541169,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.mehy.2012.06.026","type":"journal-article","created":{"date-parts":[[2012,7,21]],"date-time":"2012-07-21T21:30:35Z","timestamp":1342906235000},"page":"471-473","source":"Crossref","is-referenced-by-count":9,"title":["Eukaryotic initiation factor 5B: A new player for the anti-hepatitis C virus effect of ribavirin?"],"prefix":"10.1016","volume":"79","author":[{"given":"E.","family":"Galmozzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Aghemo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9286","key":"10.1016\/j.mehy.2012.06.026_b0005","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0140-6736(01)06102-5","article-title":"Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial","volume":"358","author":"Manns","year":"2001","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.mehy.2012.06.026_b0010","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","article-title":"PEG-interferon alpha-2a plus ribavirin for chronic hepatitis C virus infection","volume":"347","author":"Fried","year":"2002","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.mehy.2012.06.026_b0015","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/nrgastro.2010.101","article-title":"Pegylated interferons alpha2a and alpha2b in the treatment of chronic hepatitis C","volume":"7","author":"Aghemo","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.mehy.2012.06.026_b0020","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0168-8278(99)80093-2","article-title":"Ribavirin polarizes human T cell responses towards a Type 1 cytokine profile","volume":"30","author":"Tam","year":"1999","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.mehy.2012.06.026_b0025","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0016-5085(00)70217-4","article-title":"Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C","volume":"118","author":"Cramp","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mehy.2012.06.026_b0030","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1053\/j.gastro.2010.03.037","article-title":"Ribavirin improves early responses to peginterferon through improved interferon signaling","volume":"139","author":"Feld","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mehy.2012.06.026_b0035","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0166-3542(85)90012-9","article-title":"Mode of action of ribavirin: effect of nucleotide pool alterations on influenza virus ribonucleoprotein synthesis","volume":"5","author":"Wray","year":"1985","journal-title":"Antiviral Res"},{"issue":"49","key":"10.1016\/j.mehy.2012.06.026_b0040","doi-asserted-by":"crossref","first-page":"46094","DOI":"10.1074\/jbc.C100349200","article-title":"Hepatitis C virus RNA-dependent RNA polymerase (NS5B) as a mediator of the antiviral activity of ribavirin","volume":"276","author":"Maag","year":"2001","journal-title":"J Biol Chem"},{"issue":"12","key":"10.1016\/j.mehy.2012.06.026_b0045","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1038\/82191","article-title":"The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen","volume":"6","author":"Crotty","year":"2000","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.mehy.2012.06.026_b0050","doi-asserted-by":"crossref","first-page":"6895","DOI":"10.1073\/pnas.111085598","article-title":"RNA virus error catastrophe: direct molecular test by using ribavirin","volume":"98","author":"Crotty","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"17","key":"10.1016\/j.mehy.2012.06.026_b0055","doi-asserted-by":"crossref","first-page":"8505","DOI":"10.1128\/JVI.76.17.8505-8517.2002","article-title":"Viral RNA mutations are region specific and increased by ribavirin in a full-length hepatitis C virus replication system","volume":"76","author":"Contreras","year":"2002","journal-title":"J Virol"},{"issue":"17","key":"10.1016\/j.mehy.2012.06.026_b0060","doi-asserted-by":"crossref","first-page":"8074","DOI":"10.1128\/JVI.75.17.8074-8081.2001","article-title":"Ribavirin induces error-prone replication of GB virus B in primary tamarin hepatocytes","volume":"75","author":"Lanford","year":"2001","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.mehy.2012.06.026_b0140","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.virusres.2011.02.005","article-title":"Mechanism of action of ribavirin in a novel hepatitis C virus replication cell system","volume":"157","author":"Mori","year":"2011","journal-title":"Virus Res"},{"key":"10.1016\/j.mehy.2012.06.026_b0070","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1146\/annurev.biochem.73.030403.080419","article-title":"The molecular mechanics of eukaryotic translation","volume":"73","author":"Kapp","year":"2004","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.mehy.2012.06.026_b0075","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0079-6603(01)70018-9","article-title":"Functional significance and mechanism of eIF5-promoted GTP hydrolysis in eukaryotic translation initiation","volume":"70","author":"Das","year":"2001","journal-title":"Prog Nucleic Acid Res Mol Biol"},{"issue":"1","key":"10.1016\/j.mehy.2012.06.026_b0080","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1101\/gad.12.1.67","article-title":"A prokaryotic like mode of cytoplasmic eukaryotic ribosome binding to the initiation codon during internal translation initiation of hepatitis C and classical swine fever virus RNAs","volume":"12","author":"Pestova","year":"1998","journal-title":"Genes Dev"},{"issue":"3","key":"10.1016\/j.mehy.2012.06.026_b0085","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/sj.emboj.7601549","article-title":"HCV and CSFV IRES domain II mediate eIF2 release during 80S ribosome assembly","volume":"26","author":"Locker","year":"2007","journal-title":"EMBO J"},{"issue":"8","key":"10.1016\/j.mehy.2012.06.026_b0090","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/nsmb.1445","article-title":"Eukaryotic translation initiation machinery can operate in a bacterial-like mode without eIF2","volume":"15","author":"Terenin","year":"2008","journal-title":"Nat Struct Mol Biol"},{"issue":"6767","key":"10.1016\/j.mehy.2012.06.026_b0095","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/35002118","article-title":"The joining of ribosomal subunits in eukaryotes requires eIF5B","volume":"403","author":"Pestova","year":"2000","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.mehy.2012.06.026_b0100","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1021\/bi062134g","article-title":"Kinetic analysis of the interaction of guanine nucleotides with eukaryotic translation initiation factor eIF5B","volume":"46","author":"Pisareva","year":"2007","journal-title":"Biochemistry"},{"issue":"36","key":"10.1016\/j.mehy.2012.06.026_b0105","doi-asserted-by":"crossref","first-page":"27286","DOI":"10.1016\/S0021-9258(19)74247-1","article-title":"Characterization of human type I and type II IMP dehydrogenases","volume":"268","author":"Carr","year":"1993","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.mehy.2012.06.026_b0110","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0092-8674(00)00181-1","article-title":"X-Ray structures of the universal translation initiation factor IF2\/eIF5B: conformational changes on GDP and GTP binding","volume":"103","author":"Roll-Mecak","year":"2000","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.mehy.2012.06.026_b0115","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0042-6822(03)00152-1","article-title":"The effect of ribavirin and IMPDH inhibitors on hepatitis C virus subgenomic replicon RNA","volume":"310","author":"Zhou","year":"2003","journal-title":"Virology"},{"issue":"5","key":"10.1016\/j.mehy.2012.06.026_b0120","doi-asserted-by":"crossref","first-page":"596","DOI":"10.4161\/rna.7.5.13096","article-title":"Components of the multifactor complex needed for internal initiation by the IRES of hepatitis C virus in Saccharomyces cerevisiae","volume":"7","author":"Rosenfeld","year":"2010","journal-title":"RNA Biol"},{"issue":"1","key":"10.1016\/j.mehy.2012.06.026_b0125","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.virol.2004.04.031","article-title":"Mechanism of the interferon alpha response against hepatitis C virus replicons","volume":"325","author":"Guo","year":"2004","journal-title":"Virology"},{"issue":"11","key":"10.1016\/j.mehy.2012.06.026_b0130","doi-asserted-by":"crossref","first-page":"4632","DOI":"10.1091\/mbc.E06-06-0478","article-title":"Initiation of protein synthesis by hepatitis C virus is refractory to reduced eIF2-GTP-Met-tRNA(i) ternary complex availability","volume":"17","author":"Robert","year":"2006","journal-title":"Mol Biol Cell"},{"issue":"3","key":"10.1016\/j.mehy.2012.06.026_b0135","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.antiviral.2009.05.004","article-title":"Translational insensitivity to potent activation of PKR by HCV IRES RNA","volume":"83","author":"Shimoike","year":"2009","journal-title":"Antiviral Res"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987712003039?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987712003039?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,22]],"date-time":"2022-01-22T16:02:50Z","timestamp":1642867370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987712003039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0306987712003039"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2012.06.026","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}